NewsBenzingaAnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate Benzinga 2026.09.21 20:55 (GMT+0) Open on Benzinga Other news Tolan snags $30M for its AI companion that helps users navigate life Replika’s founder built the AI assistant she pitched at Disrupt 12 years ago Tenstorrent hits $6.2B valuation to scale open-weight AI chips Homebuilder Sentiment Hits 2012 Lows As Stocks Trade Like They Did During COVID-19 Pandemic Rain Says Western Union's Stablecard Is Live in 37 Markets FDA Clears GSK Drug That Could Change How Certain Rectal Cancers Are Treated
